Targovax ASA (GB:0RIS) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Circio Holding ASA is advancing its innovative circular RNA technology, aiming to revolutionize nucleic acid medicine with its proprietary circVec platform. This technology promises enhanced and durable protein expression, positioning itself as a potential future standard in therapeutic applications. Additionally, Circio is actively developing a cancer vaccine, TG01, targeting KRAS mutations, with ongoing clinical trials in the USA and Norway.
For further insights into GB:0RIS stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- Nike Q2 Earnings Preview: Analysts Expect a Decline in Earnings and Sales
- Salesforce Hits 1,000 Agentforce Deals, Launches Agentforce 2.0
- Starbucks’ Union Threatens Strike at the 11th Hour
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
